Start HAQ | 1.556 | Normal (1.55, 0.61) |
Utility/HAQ regression gradient | 0.76–0.28 HAQ34 | Bivariate normal (0.76, 0.023, −0.28, 0.003, −0.6) |
HAQ progression due to no response | 0.06617 | Triangular (0.016, 0.035, 0.066) |
HAQ progression: response to DMARD | 0.01717 | Normal (0.017, 0.02) |
HAQ progression: response to biological agent | 0.01717 | Triangular (0, 0.016, 0.017) |
HAQ direct cost regression (SEK) | 119210–1416 HAQ3 | Bivariate normal (191910, 461, −1416, 421, 0.6) |
Response decrease OR | 0.9826 | Normal (0.98, 0.0045) |
Relative risk of mortality due to RA | 1.6340 | Normal (1.63, 0.14) |